ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 1842 • ACR Convergence 2023

    Reduction in the Concomitant Ordering of Erythrocyte Sedimentation Rate and C-Reactive Protein Within the Rheumatology Clinics at an Academic Medical Center

    Ruchi Desai1, Nainesh Shah1, Ray Zhang1, Maria Bacalao2, Haidy Galous3, David Karp1 and Puneet Bajaj1, 1UT Southwestern Medical Center, Dallas, TX, 2UT Southwestern, Dallas, TX, 3UT Southwestern, Southlake, TX

    Background/Purpose: ESR and CRP are two laboratory values usedto assess inflammation. There is data to support that CRPis superior to ESR to detect/monitor inflammation or…
  • Abstract Number: 2092 • ACR Convergence 2023

    Feasibility and Efficacy of Culturally Appropriate Spanish Language-First Patient Education for Rheumatoid Arthritis

    Daniel Hernandez1, Julio Bravo2, Juan Maya Villamizar3, Oscar Soto4, Angel Tapia5, Guillermo Valenzuela6, W. Benjamin Nowell7 and Shilpa Venkatachalam8, 1Global Healthy Living Foundation, St. Johns, FL, 2Novant, Winston-Salem, NC, 3Rheumatology Center of Palm Beach, PLLC, Boca Raton, FL, 4Mindful Rheumatix and Medical Research Group, San Juan, PR, 5Global Healthy Living Foundation, Upper Nyack, NY, 6Integral Rheumatology & Immunology Specialists, Plantation, FL, 7Global Healthy Living Foundation, Nyack, NY, 8Global Healthy Living Foundation, New York, NY

    Background/Purpose: Spanish-speaking patients with rheumatic arthritis (RA) need RA education that is medically accurate, conversational, and engaging. Our study examined the feasibility and efficacy of…
  • Abstract Number: 0156 • ACR Convergence 2023

    Factors Associated with Adherence to Cervical Cancer Screening in Ethnically Diverse Women with Systemic Lupus Erythematosus

    Sebastian Bruera1, Savannah Bowman1, Yinan Huang2, Maria Suarez-Almazor3, Grace Lo1, Elizabeth Chiao4, Maria A. Lopez-Olivo4 and Sandeep Agarwal1, 1Baylor College of Medicine, Houston, TX, 2Department of Pharmacy Administration, University of Mississippi School of Pharmacy, Oxford, MS, 3MD Anderson Cancer Center, Houston, TX, 4The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Women living with systemic lupus erythematosus (SLE) are at an increased risk of infections from human papillomavirus (HPV), and cervical cancer, especially women with…
  • Abstract Number: 0187 • ACR Convergence 2023

    Advancing Health Equity with Lupus Stakeholders to Close Care Gaps and Disparities

    Shalvi Parikh1, Monica Messina1, Shivani Garg1, Sancia Ferguson2, Edmond Ramly3, Andrea Gilmore-Bykovskyi4, Katrina Phelps5 and Christie M. Bartels6, 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin, Madison, WI, 3Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin School of Medicine and Public Health, Madison, WI, 5School of Nursing, University of Wisconsin-Madison, Madison, WI, 6University of Wisconsin, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Systemic lupus erythematosus (SLE) care and outcomes are associated with significant racial and socioeconomic disparities in the US, particularly among young Black and Hispanic/Latina…
  • Abstract Number: 1004 • ACR Convergence 2023

    Telerheumatology Shared-Care Model: Leveraging the Expertise of an ACPAC-Trained Extended Role Practitioner (ERP) in Rural-Remote Ontario

    Amanda Steiman1, Taucha Inrig2, Katie Lundon3, Jocelyne Murdoch4 and Rachel Shupak5, 1Sinai Health System, Toronto, ON, Canada, 2St. Michael's Hospital, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4Arthritis Society, Toronto, ON, Canada, 5St. Michael's Hospital/University of Toronto, Toronto, ON, Canada

    Background/Purpose: A  shortage of Rheumatologists has led to gaps in inflammatory arthritis (IA) care in Canada. Amplified in rural-remote communities, the number of Rheumatologists practicing…
  • Abstract Number: 1843 • ACR Convergence 2023

    Detection of Clinically Relevant Subgroups in Patients Undergoing Knee Replacement Using Machine Learning

    Brooke McGinley1, Gabriela Rabasa1, Jean Liew1, Tuhina Neogi2, David Felson1 and Michael LaValley3, 1Boston University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA

    Background/Purpose: In the US the lifetime risk for Knee Replacement surgery (KR) is 7% for men and 9.5% for women, and this accounts for substantial…
  • Abstract Number: 2142 • ACR Convergence 2023

    Adherence Patterns in Rheumatoid Arthritis Patients Receiving a Janus Kinase (JAK) Inhibitor or a Tumor Necrosis Factor α Inhibitor (TNFi) After the Addition of a Black Box Warning to JAK Inhibitors

    W. Cliff Rutter, Kunal Patel, Samantha Delgado, Guy Cozzi, Elisea Avalos-Reyes, Will Cavers, Chen Liu, Rashmi Grover, Lucia Feczko and Kjel Johnson, CVS Health, Woonsocket, RI

    Background/Purpose: In 2021, the FDA concluded that there is an increased risk of serious heart-related events with the Janus Kinase (JAK) inhibitor tofacitinib, which is…
  • Abstract Number: 0158 • ACR Convergence 2023

    Analyzing User Log Data to Track Provider Use of an EHR-based Dashboard for Rheumatoid Arthritis Outcomes

    Lindsay Jacobsohn1, Emma Kersey1, Jing Li1, Catherine Nasrallah1, Cherish Wilson2, Cammie Young3, Cammie Young3, Alicia Hamblin1, Jinoos Yazdany1 and Gabriela Schmajuk2, 1University of California San Francisco, San Francisco, CA, 2UCSF / SFVA, San Francisco, CA, 3University of California San Francisco, Oakland, CA

    Background/Purpose: We developed an electronic health record (EHR)-based patient-facing sidecar dashboard application to display RA outcomes, including disease activity, functional status, and pain scores over…
  • Abstract Number: 0214 • ACR Convergence 2023

    COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice Network

    Emily Holladay1, Amy S. Mudano2, Fenglong Xie2, Patrick Stewart3, Lesley E. Jackson1, Maria I. ("Maio") Danila4, Kelly Gavigan5, W. Benjamin Nowell6, Shilpa Venkatachalam7 and Jeffrey Curtis1, 1University of Alabama at Birmingham, Birmingham, AL, 2Illumination Health, Hoover, AL, 3Illumination Health, Birmingham, AL, 4University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 5Global Healthy Living Foundation, Upper Nyack, NY, 6Global Healthy Living Foundation, Nyack, NY, 7Global Healthy Living Foundation, New York, NY

    Background/Purpose: COVID-19 vaccine uptake in autoimmune and inflammatory rheumatic disease (AIIRD) patients is an area of concern to rheumatologists and other providers. These patients are…
  • Abstract Number: 1006 • ACR Convergence 2023

    Use of Implementation Strategies to Promote Adherence of Knee Osteoarthritis Guidelines and Improve Patient Outcomes: A Systematic Review

    Michelle Ramirez1, Rebecca Fillipo1, Connor Drake1, Lesley Skalla2, Kelli Allen3, Amanda Nelson4 and Maggie Horn1, 1Duke University School of Medicine, Durham, NC, 2Duke University Medical Center Library & Archives, Durham, NC, 3University of North Carolina, Durham, NC, 4University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Despite the development of care models and practice guidelines the translation of knee osteoarthritis guidelines to practice remains suboptimal. Theoretically informed implementation strategies may…
  • Abstract Number: 1844 • ACR Convergence 2023

    Are Patients with Inflammatory Rheumatic Diseases Ready for Studies with Medical Cannabis? – Results from a Digital Survey

    Jutta Richter1, Aurelia Beichert2, Tim Filla2, Matthias Schneider3, Joerg Distler4 and Inna Frohne2, 1Clinic for Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Düsseldorf, Germany, 2Clinic for Rheumatology and Hiller Research Unit University Clinic Duesseldorf, Düsseldorf, Germany, 3Heinrich-Heine-Universitaet Duesseldorf, Duesseldorf, Germany, 4Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany; Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany

    Background/Purpose: There is an increasing demand from patients for medical cannabis in the German population [1]. Although medical cannabis might be used to treat pain…
  • Abstract Number: 2169 • ACR Convergence 2023

    Cost-utility of a Progressive Spacing of Tocilizumab or Abatacept in Patients with Rheumatoid Arthritis in Sustained Remission: A Medico-economic Analysis of the Towards the Lowest Efficacious Dose Trial

    Joanna Kedra1, Benjamin Granger2, Lina El Houari3, Florence Tubach4 and Bruno Fautrel5, 1Sorbonne Université, IPLESP, and Pitié-Salpêtrière Hospital, Paris, France, 2Sorbonne Université, INSERM, and Pitié Salpêtrière Hospital, Paris, France, 3Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France, 4Centre de pharmaco-épidémiologie de l'APHP, Paris, France, 5Sorbonne Université APHP, Paris, France

    Background/Purpose: Biologic Disease Modifying Anti-Rheumatic Drugs (bDMARDs) progressive tapering is a real opportunity in people living with rheumatoid arthritis (RA) having achieved remission both from…
  • Abstract Number: 0159 • ACR Convergence 2023

    Understanding the Economic Impact of Autoimmune Eye Disease in the United States

    Krati Chauhan1, Steven Scaife2 and Michael Buhnerkempe1, 1Southern Illinois University - School of Medicine, Springfield, IL, 2Southen Illinois University - School of Medicine., Springfield, IL

    Background/Purpose: Eye involvement is an important cause of morbidity in rheumatology patients. Inflammatory eye diseases include conditions like scleritis, uveitis, retinitis and orbital inflammation. The…
  • Abstract Number: 0299 • ACR Convergence 2023

    Trends and Outcomes of Hospitalized Patients with Idiopathic Inflammatory Myopathy and Venous Thromboembolism: A Nationwide Inpatient Sample Analysis from US (2016-2019)

    Haseeb Chaudhary1, Biraj Shrestha2, Sarah Abi Doumeth3 and Maya Mattar4, 1Case Western Reserve University, Westlake, OH, 2Tower Health System, Reading, PA, 3Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, 4Louis Stokes VA Medical Center, Cleveland, OH

    Background/Purpose: Recent evidence suggests increased prevalence of venous thromboembolism (VTE) in patients with idiopathic inflammatory myopathies (IIM). The literature on the clinical implications of VTE…
  • Abstract Number: 1008 • ACR Convergence 2023

    Identifying Inflammatory Arthritis Ambulatory Care Service Model Enhancements Needed to Reduce Avoidable Emergency Department Use

    Emilie Pianarosa1, Pamela Roach1, Patrick McLane2, Meghan Elliott1, Brian Holroyd3, Shanon McQuitty4, Steven Katz3, Nazret Russon2, Katie Lin1, Claire Barber1 and Cheryl Barnabe1, 1University of Calgary, Calgary, AB, Canada, 2Alberta Health Services, Edmonton, AB, Canada, 3University of Alberta, Edmonton, AB, Canada, 4Arthritis Research Canada, Vancouver, BC, Canada

    Background/Purpose: Emergency departments (ED) become a location for non-urgent care when ambulatory care systems are not sufficient. We aim to describe contributing factors to the…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 23
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology